Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsShares RepurchasedShort-Term Debt issuances
Ratios

Select Medical Holdings (SEM) Accumulated Depreciation & Amortization (2016 - 2024)

Historic Accumulated Depreciation & Amortization for Select Medical Holdings (SEM) over the last 16 years, with Q4 2024 value amounting to $203.9 million.

  • Select Medical Holdings' Accumulated Depreciation & Amortization fell 232.25% to $203.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $203.9 million, marking a year-over-year decrease of 232.25%. This contributed to the annual value of $203.9 million for FY2024, which is 232.25% down from last year.
  • Per Select Medical Holdings' latest filing, its Accumulated Depreciation & Amortization stood at $203.9 million for Q4 2024, which was down 232.25% from $208.7 million recorded in Q4 2023.
  • In the past 5 years, Select Medical Holdings' Accumulated Depreciation & Amortization registered a high of $1.1 billion during Q4 2021, and its lowest value of $203.9 million during Q4 2024.
  • In the last 5 years, Select Medical Holdings' Accumulated Depreciation & Amortization had a median value of $208.7 million in 2023 and averaged $557.8 million.
  • In the last 5 years, Select Medical Holdings' Accumulated Depreciation & Amortization skyrocketed by 1261.85% in 2020 and then tumbled by 8190.58% in 2022.
  • Select Medical Holdings' Accumulated Depreciation & Amortization (Quarter) stood at $1.0 billion in 2020, then grew by 10.11% to $1.1 billion in 2021, then plummeted by 81.91% to $205.8 million in 2022, then increased by 1.42% to $208.7 million in 2023, then decreased by 2.32% to $203.9 million in 2024.
  • Its Accumulated Depreciation & Amortization stands at $203.9 million for Q4 2024, versus $208.7 million for Q4 2023 and $205.8 million for Q4 2022.